Glioma of Brain, Recurrence
Conditions
Brief summary
A Prospective Exploratory Clinical Study to explore the efficacy of Hospital Traditional Chinese Medicine Preparation Kangliuwan for Recurrent Grade IV Glioma.
Interventions
None listed
Sponsors
Xuanwu Hospital, Beijing
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
1. The patient signed informed consent voluntarily; 2. The age of patient is between 18 and 80 years; 3. KPS score ≥40 ; The patient has normal liver and kidney function Normal heart function Better follow-up and compliance;
Exclusion criteria
1. The patient did not sign informed consent or signed unvoluntarily. 2. Non-glioma patients 3. Active infection 4. Human immunodeficiency virus (HIV) positive 5. Hepatitis C or hepatitis B infective 6. Pregnancy or breast-feeding women 7. Patients did not agree to use effective contraception during treatment and the following 3 months. 8. Patients also participated in other clinical studies. 9. The subjects researchers believe are not suitable for participation or completion of the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in tumor volume | 3 months | the volume of tumor decreased after taking Kangliuwan |
Countries
China
Contacts
Primary ContactQingtang Lin, MD. Ph.D
Backup ContactGe Sun, B.A.
Outcome results
None listed